On February 9th, 2015, the Boye lab will be presenting 3 major research projects at the UF College of Medicine’s Celebration of Research. Join us in the O’Connell center to hear Shreyasi Choudhury, Miranda White and Tyler McCullough present their work!…
A link to the article “Gene Therapy: Hope for the Blind?” can be found here: http://search.ivanhoe.com/channels/p_channelstory.cfm?storyid=34267&channelid=CHAN-100008…
“High Resolution Transcriptomics: Dissecting the Molecular Program Underlying Retinal Development”- Rahul Kanadia…
DECEMBER 5th!!! Here we come Denver!…
Presented by the Center for Vision Research and Institute on Aging “Mitochondrial Function and Metabolism in Aging and Vision” McKnight Brain Institute DeWeese Auditorium (LG-101A) December 8, 2014, 8:00-5:00 …
On October 23rd, Miranda White passed her qualifying exam and officially became a ‘doctoral candidate’. Congratulations!…
The collaborative efforts between Dr. Boye and Genzyme to develop a gene therapy for GUCY2D LCA1 were recently featured in a press release. A link to the aritcle can be found here: http://news.genzyme.com/press-release/genzyme-collaborates-gene-therapy-rare-disease-causes-childhood-blindness…
Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the establishment of a research collaboration with the University of Florida and the University of Pennsylvania to develop a gene therapy for the treatment of a rare genetic disease that causes childhood blindness. Leber congenital amaurosis type 1 (LCA-1)…
The team is happy to welcome its two newest members. In August, postdoctoral associate Shreyasi Choudhury, Ph.D. and laboratory assistant Tyler McCullough, M.S. joined the group. They bring with them valuable experience in vision research and have already proven to be integral parts of our operation. Welcome Shreyasi and Tyler!…
Much work is being done with Adeno-associated virus (AAV) vectors for application in retinal gene therapy, with modifications being made to the capsid and genome of the vector to generate novel variants with unique transduction profiles, according to Shannon Boye, PhD…
